Home > Journals > International Angiology > Past Issues > International Angiology 2017 June;36(3) > International Angiology 2017 June;36(3):228-36

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

INTERNATIONAL ANGIOLOGY

A Journal on Angiology


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,37


eTOC

 

ORIGINAL ARTICLE  


International Angiology 2017 June;36(3):228-36

DOI: 10.23736/S0392-9590.16.03732-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations

Haitham ALI 1, Mahmoud SALEH 1, Walid MOHAMMED 2

1 Vascular and Endovascular Surgery Department, Assiut University Hospitals, Assiut, Egypt; 2 Vascular Surgery Department, Qena University Hospital, Qena, Egypt


PDF  


BACKGROUND: The aim of our study was to report our experience regarding the safety, efficacy of duplex-guided polidocanol (POL) foam sclerotherapy on the overall status of signs and symptoms in patients with venous malformations (VMs).
METHODS: Thirty seven patients with symptomatic extratruncular VMs were treated with duplex-guided POL foam sclerotherapy using Tessari’s method. Twenty five patients had limited VMs, while twelve had infiltrating VMs. Postsclerotherapy surveillance was done 6 months after the last sclerotherapy session and comprised both clinical and duplex evaluation. Clinical evaluation entailed a patient self-assessment questionnaire using a four-point scale to rate the degree of symptoms improvement as follows: disappeared, decreased, worsened, or recurred. Findings obtained by duplex scanning were divided into four groups: 1) disappeared group; 2) partially recanalized group; 3) totally recanalized group; and 4) worsened group.
RESULTS: There were 20 males and 17 females with mean age of 22.8±5.5 years. There was a significant reduction in the total amount of POL (P=0.0037), the number of sclerotherapy sessions was significantly lesser (P=0.0019), and treatment success was significantly higher (P=0.0495) in patients with limited VMs in comparison to those with infiltrating VMs. No major complications related to sclerotherapy were encountered in both groups.
CONCLUSIONS: Polidocanol foam sclerotherapy is effective, and safe for treatment of VMs, with high success rate and low risk of major complications. Although associated with relatively high recurrence rate compared with ethanol sclerotherapy, this can be overcome by additional treatment sessions, given the relative simplicity, speed, and safety.


KEY WORDS: Sclerotherapy - Vascular malformations - Polidocanol

top of page

Publication History

Issue published online: March 27, 2017
Article first published online: June 30, 2016
Manuscript revised: June 21, 2016
Manuscript accepted: June 23, 2016
Manuscript received: May 17, 2016

Cite this article as

Ali H, Saleh M, Mohammed W. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations. Int Angiol 2017;36:228-36. DOI: 10.23736/S0392-9590.16.03732-9

Corresponding author e-mail

haithamvascular@gmail.com